Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Retrospective Correlation of the Circulation Time of Test Bolus Injections in MR Angiography and Cardiac Function

Version 1 : Received: 25 March 2024 / Approved: 26 March 2024 / Online: 26 March 2024 (14:23:26 CET)

How to cite: Möller, D.F.; Mohorko, B.; Aschauer, T.E.; Schwager, T.; Aschauer, M.A. Retrospective Correlation of the Circulation Time of Test Bolus Injections in MR Angiography and Cardiac Function. Preprints 2024, 2024031609. https://doi.org/10.20944/preprints202403.1609.v1 Möller, D.F.; Mohorko, B.; Aschauer, T.E.; Schwager, T.; Aschauer, M.A. Retrospective Correlation of the Circulation Time of Test Bolus Injections in MR Angiography and Cardiac Function. Preprints 2024, 2024031609. https://doi.org/10.20944/preprints202403.1609.v1

Abstract

This retrospective study examines 248 test-bolus examinations preceding contrast-enhanced magnetic resonance angiography (CE-MRA) to extract clinically relevant data for critical limb ischemia (CLI) management. Methods involved a retrospective review of test-bolus exams, analysing 60 graphs for time-to-peak (TTP), full-width half-maximum (FWHM) time, and time to continual rise in signal intensity. These values were correlated with heart function parameters (ejection fraction, ASA-Classification, Lee-Index, and MET-Score). Results indicate a mean TTP of 31.2 ± 7.3s, showing a correlation between ejection fraction and ASA classification. Patients with atrial fibrillation exhibited prolonged TTP compared to those without. Despite population heterogeneity, findings facilitate risk stratification for limb-saving interventions in CLI. TTP emerges as a potential clinical cardiovascular parameter and a risk factor for vascular interventions. Given the variation in injection protocols across centres, this study underscores the importance of precise bolus arrival time documentation for future multicentre studies.

Keywords

test-bolus examination; magnetic resonance angiography; time-to-peak; peripheral arterial disease

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.